Logo image of NBSE

NEUBASE THERAPEUTICS INC (NBSE) Stock Analyst Ratings

NASDAQ:NBSE - Nasdaq - US64132K2015 - Common Stock - Currency: USD

0.378  -0.01 (-3.2%)

After market: 0.42 +0.04 (+11.11%)

Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to NBSE. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 142.8. This target is 37677.78% above the current price.
NBSE was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about NBSE.
In the previous month the buy percentage consensus was at a similar level.
NBSE was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

NBSE Historical Analyst RatingsNBSE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -73 -66 -59 -52 -45 -38 -31 -24 -17 -10 -3 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.38141.40142.80142.80147.00 - 37,307.41% 37,677.78% 37,677.78% 38,788.89%

Related screens

NBSE Current Analyst RatingNBSE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2022-10-21 Oppenheimer Downgrade Outperform -> Perform
2022-10-18 RBC Capital Downgrade Outperform -> Sector Perform
2022-10-17 Chardan Capital Downgrade Buy -> Neutral
2022-08-12 Chardan Capital Maintains Buy
2022-05-31 HC Wainwright & Co. Maintains Buy
2022-05-13 Chardan Capital Maintains Buy
2021-06-01 HC Wainwright & Co. Maintains Buy
2021-02-12 HC Wainwright & Co. Maintains Buy